VILLA, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 6.971
NA - Nord America 821
AS - Asia 700
Continente sconosciuto - Info sul continente non disponibili 117
SA - Sud America 89
AF - Africa 15
OC - Oceania 3
Totale 8.716
Nazione #
IT - Italia 6.855
US - Stati Uniti d'America 771
SG - Singapore 269
CN - Cina 178
VN - Vietnam 123
BD - Bangladesh 50
BR - Brasile 48
FR - Francia 47
HK - Hong Kong 30
CA - Canada 18
DE - Germania 18
GB - Regno Unito 14
AR - Argentina 10
EC - Ecuador 10
MX - Messico 10
CO - Colombia 9
JP - Giappone 9
ID - Indonesia 7
IN - India 6
CH - Svizzera 5
IQ - Iraq 5
ZA - Sudafrica 5
BO - Bolivia 4
PH - Filippine 4
PL - Polonia 4
VE - Venezuela 4
CL - Cile 3
ES - Italia 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
NL - Olanda 3
NP - Nepal 3
RO - Romania 3
TR - Turchia 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
AU - Australia 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
FI - Finlandia 2
GT - Guatemala 2
IE - Irlanda 2
NI - Nicaragua 2
PK - Pakistan 2
PR - Porto Rico 2
PT - Portogallo 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AL - Albania 1
BE - Belgio 1
BS - Bahamas 1
BZ - Belize 1
DZ - Algeria 1
GA - Gabon 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NC - Nuova Caledonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SI - Slovenia 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.600
Città #
Genova 3.952
Genoa 1.788
Rapallo 554
Vado Ligure 501
San Jose 150
Singapore 125
Ashburn 82
Lauterbourg 45
Ho Chi Minh City 37
Hong Kong 28
New York 28
Beijing 27
Hanoi 21
Santa Clara 20
Bordighera 19
Frankfurt am Main 16
Dallas 15
Chicago 13
Los Angeles 13
Brooklyn 10
San Francisco 9
Tokyo 9
Da Nang 7
Milan 6
Rome 6
Tampa 6
Council Bluffs 5
Mexico City 5
Orem 5
Philadelphia 5
Zurich 5
Atlanta 4
Long Beach 4
Louisville 4
Miami 4
Montreal 4
Nashville 4
Phoenix 4
Pittsburgh 4
Quito 4
São Paulo 4
Tianjin 4
Warsaw 4
Buffalo 3
Detroit 3
Haiphong 3
Hải Dương 3
Johannesburg 3
La Paz 3
London 3
Medellín 3
Nairobi 3
Riobamba 3
Savannah 3
Shanghai 3
St Louis 3
Toms River 3
Akron 2
Amsterdam 2
Azusa 2
Barcelona 2
Berazategui 2
Biên Hòa 2
Brasília 2
Canary Wharf 2
Caracas 2
Charlotte 2
Chennai 2
Cincinnati 2
Clanton 2
Columbus 2
Copenhagen 2
Denver 2
Dublin 2
Fresno 2
Golden 2
Guangzhou 2
Guatemala City 2
Helsinki 2
Houston 2
Jakarta 2
Kyiv 2
Lawrenceville 2
Managua 2
Manchester 2
Memphis 2
Mount Airy 2
Nanjing 2
Naples 2
Nha Trang 2
Nicosia 2
Ninh Bình 2
Norristown 2
Plano 2
Plymouth 2
Princeton 2
Rio Rancho 2
Rio de Janeiro 2
San Antonio 2
San Diego 2
Totale 7.688
Nome #
Characterization of the pro-apoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231 279
Amyloid precursor protein modulates ERK1/2 signaling 278
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 269
Calcium binding promotes Prion Protein fragment 90-231 conformational change toward a membrane destabilizing and cytotoxic structure 242
Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro 240
Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis 228
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 227
Apoptotic cell death and impairment of L-type voltage sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126 226
Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231 221
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 211
Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic 210
Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death 210
Different structural stability and toxicity of PrPARR and PrPARQ sheep prion protein variants 205
Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90–231 Neurotoxic Effects in Cerebellar Granule Neurons 202
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 191
Conformation dependent pro-apoptotic activity of the recombinant human prion protein fragment 90-231 191
ACTIVATION OF AUTOPHAGY PATHWAY AS NEUROPROTECTIVE MECHANISM AGAINST AMYLOIDOGENIC PRION PEPTIDE 191
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 189
Addressing thermal and mechanical stability of human prion protein with single molecule and ensemble measurements 186
ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation 185
Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction 183
Celecoxib, a COX-2 inhibitor, blocks microglial activation induced by a neurotoxic conformer of hPrP90-231 181
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 181
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 178
Excitotoxicity Through NMDA Receptors Mediates Cerebellar Granule Neuron Apoptosis Induced by Prion Protein 90-231 Fragment 178
Aminoterminally truncated human Prion protein fragment 90-231 forms intracellular aggregates and causes lysosomal loss of impermeability 174
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 173
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 167
Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation 165
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 163
Role of prion protein aggregation in neurotoxicity 160
Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein 160
p38 MAP Kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells 158
High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein 153
Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity 150
Molecular mechanisms involved in the aggregation and fibril formation of the recombinant human prion fragment PrP90-231 138
Prion protein fragment 90-231 induces microglia activation: role of ERK1/2 and p38 MAP kinases in nitric oxide production and CCL5 secretion 132
Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor 3 (SSTR3) mediated regulation of endothelial NOS and MAP kinase activities” 128
Nitric oxide production stimulated by the basic fibroblast growth factor requires the synthesis of ceramide 128
Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling 127
Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231 (hPrP90-231), as possible mechanism of its neurotoxic effects 126
Study of the Molecular Mechanism Responsible of the Conformational Changes Induced by E200K and D202N Pathological PrP Mutation 121
Study of the molecular mechanisms responsible of the transition of the prion protein fragment 90-231 in a neurotoxic conformation. 120
Expression of somatostatin receptors mRNA in human meningiomas and their implication in in vitro antiproliferative activity 120
Molecular mechanisms mediating the neuroprotective effects of quinacrine and minocycline on cell death induced by the prion protein fragment 90-231 (hPrP90-231) 114
Somatostatinergic control of Kaposi’s sarcoma growth through the inhibition of angiogenesis 104
Somatostatin receptor expression in stromal tumors of the gastrointestinal 98
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro 96
Neurotoxicity of the recombinant prion protein fragment 90-231 in SH-SY5Y cells is dependent on its conversion in beta-structured-isoform 95
Somatostatin receptor expression in patients with stromal tumors of the gastrointestinal tract 93
The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 71
Totale 8.716
Categoria #
all - tutte 26.653
article - articoli 24.820
book - libri 0
conference - conferenze 1.437
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 396
Totale 53.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022581 0 0 35 68 20 52 61 149 20 54 32 90
2022/2023648 48 43 5 64 110 116 1 54 94 5 101 7
2023/2024346 22 33 7 48 22 87 28 20 17 6 24 32
2024/20251.197 32 68 30 117 165 123 92 232 39 44 122 133
2025/20261.942 243 51 252 184 244 141 265 91 106 198 99 68
2026/2027516 258 173 85 0 0 0 0 0 0 0 0 0
Totale 8.716